Physician profile
Timothy S Webb
NPI 1912961715
$572.60
in general payments reported to CMS, 2019-2025
17 companies · $61.79 in 2025
The $61.79 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $59.42 · 2021: $91.46 · 2022: $94.81 · 2023: $68.02 · 2024: $47.96 · 2025: $61.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.97 | 2021-2024 | Vraylar |
| Novo Nordisk INC | $78.22 | 2019-2021 | |
| Amgen INC. | $58.76 | 2019-2025 | Evenity, Repatha, Otezla |
| Sunovion Pharmaceuticals INC. | $50.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.50 | 2019-2020 | |
| Dexcom, INC. | $32.58 | 2022 | |
| Glaxosmithkline, LLC. | $29.96 | 2024-2025 | Bexsero, Rotarix |
| Insulet Corporation | $18.78 | 2024 | Omnipod |
| Boston Scientific Corporation | $18.44 | 2021 | |
| Genentech USA, INC. | $16.20 | 2019 | |
| Beone Medicines USA, INC. | $15.28 | 2025 | Brukinsa |
| Lilly USA, LLC | $15.04 | 2023 | Jardiance, Zepbound |
| Eisai INC. | $14.68 | 2020 | |
| Pfizer INC. | $12.69 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.90 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.23 | 2020 | |
| Tandem Diabetes Care, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.